Profil bibliographique

M. Van Looveren

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

29Publications signalées

1186Citations signalées

0Affiliations récentes

Domaines associés

Bacterial Infections and VaccinesPneumonia and Respiratory InfectionsSalmonella and Campylobacter epidemiologyAntibiotic Resistance in BacteriaReproductive tract infections research

Publications récentes

Accès ouvert 2023 article

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

E Choi, Boris Lacarra, Muhammed O. Afolabi, Boni Maxime Ale et autres

18 citationsThe Lancet Global Health

Accès ouvert 2021 article

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno, Babajide Keshinro et autres

98 citationsThe Lancet Infectious Diseases

Accès ouvert 2020 article

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz et autres

172 citationsThe Lancet Infectious Diseases

2006 article

Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study

Fiona Mackenzie, Julie Bruce, M. Van Looveren, Giuseppe Cornaglia et autres

16 citationsClinical Microbiology and Infection

2006 article

Étude de souches de Neisseria meningitidis sérogroupe B isolées à Casablanca par multilocus sequence typing et électrophorèse en champ pulsé

Khalid Zerouali, Philippe Castelli, M. Van Looveren, Naïma El Mdaghri et autres

2 citationsPathologie Biologie

2005 article

High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients

K. Goethaert, M. Van Looveren, Christine Lammens, Hilde Jansens et autres

66 citationsClinical Microbiology and Infection

2004 article

Antimicrobial resistance of Acinetobacter spp. in Europe

M. Van Looveren, Herman Goossens

329 citationsClinical Microbiology and Infection

2003 article

Antimicrobial Susceptibilities of Neisseria gonorrhoeae Strains Isolated in Java, Indonesia

Margareta Ieven, M. Van Looveren, Sunarjati Sudigdoadi, Yeva Rosana et autres

28 citationsSexually Transmitted Diseases

2003 conference-paper

Epidemiological survey of Giardia duodenalis in dairy calves in the province of East-Flanders, Belgium

Thomas Geurden, Edwin Claerebout, Dirk Berkvens, M. Van Looveren et autres

0 citationsGhent University Academic Bibliography (Ghent University)

2003 article

Centra voor Moleculaire Diagnostiek (CMD's)

M. Van Looveren, H. Goossens

0 citations

2001 article

Interpreting the rising incidence of meningococcal disease in Belgium: the contribution of molecular typing

M. Van Looveren, Dominique A. Caugant, Sabine Chapelle, Françoise Carion et autres

10 citationsJournal of Medical Microbiology

Accès ouvert 2001 article

Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium

M. Van Looveren

165 citationsJournal of Antimicrobial Chemotherapy

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.